Respected Physician Dr. Carlos Aguirre Publishes Results on Effects of CBD on Childhood Epilepsy - Medical Marijuana, Inc.
The study, performed by renowned physician Dr. Carlos Aguirre-Velazquez, surveyed parents in Mexico and the rest of Latin America who have used CBD as a treatment option for their children’s refractory epilepsy. The results of the study have been recently published in Neurology Research International.
In Dr. Aguirre’s study, structured online surveys were used to record the experiences of parents of children with refractory epilepsy who used medicinal cannabis as a treatment option. In the study, 53 epilepsy cases in children aged between 9 months and 18 years were identified.
The product most commonly used by patients in the survey was HempMeds® Mexico’s flagship product, Real Scientific Hemp Oil-X™ (RSHO-X™). RSHO-X™ was the first cannabis-based product to receive COFEPRIS approval for import into Mexico and is 100% THC-free.
According to the study, several forms of childhood epilepsy were examined. In the 43 cases involving Mexican patients, the diagnoses were as follows: 20 cases (47%) had Lennox-Gastaut syndrome (LGS); 13 cases (30%) had unspecified refractory epilepsy (URE); 8 cases (19%) had West syndrome (WS); 1 case (2%) had Doose syndrome (DS); and 1 case (2%) had Ohtahara syndrome (OS).
- HempMeds® Mexico Cuts Ribbon on Local Office, Names New General Manager Raul Elizalde - Medical Marijuana, Inc.www.medicalmarijuanainc.comJune 29, 2017
- Mexico To Supply Citizens With Medical Marijuana, Inc.’s Productsherb.co
- Research in Mexico Including Medical Marijuana, Inc.’s RSHO-X Reports Efficacy of CBD to Treat Refractory Epilepsy in Children - Medical Marijuana, Inc - Investorsinvestors.medicalmarijuanainc.comSeptember 30, 2016
- Webinar Wednesday Recap with Medical Marijuana Inc. CEO Dr. Stuart Tituskannaway.comJanuary 24, 2019